Hidden sleep danger for hodgkin survivors: study investigates

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

HODGKIN LYMPHOMA SURVIVOR ELIGIBILITY CRITERIA Inclusion Criteria (Hodgkin Lymphoma Survivor): * Current participant in the SJLIFE clinical trial ongoing at St. Jude Children's Research Hospital (SJCRH) and was treated with thoracic radiation for Hodgkin lymphoma * Currently ≥ 18 years of age * ≥ 5 years from original diagnosis Exclusion Criteria (Hodgkin Lymphoma Survivor): * History of cranial or total-body radiation therapy * History of intrathecal Methotrexate, high-dose Methotrexate, or high-dose Cytarabine. * History of head injury or diagnosis of a genetic disorder associated with neurocognitive impairment * History of a neurodevelopmental disorder or birth complication associated with neurocognitive impairment * History of congenital heart disease reported in the literature to be associated with neurocognitive status as determined by the PIs * Currently pregnant * Secondary central nervous system (CNS) neoplasm COMPARISON GROUP (CONTROL) ELIGIBILITY CRITERIA Inclusion Criteria (Comparison Group): * Research participant is a sibling, parent, relative or friend of a current or former St. Jude patient * Research participant must be at least 18 years of age at the time of the scheduled evaluation Exclusion Criteria (Comparison Group): * History of cranial, total-body or thoracic radiation therapy * History of intrathecal Methotrexate, high-dose Methotrexate, or high-dose Cytarabine. * History of head injury or diagnosis of a genetic disorder associated with neurocognitive impairment * History of a neurodevelopmental disorder or birth complication associated with neurocognitive impairment * History of congenital heart disease reported in the literature to be associated with neurocognitive status as determined by the PIs * Currently pregnant * History of cancer * 1st degree relative of a survivor included in the current study.